Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-10-22

Clinical Trial Update: A Study to Monitor Patients With Primary or Early HIV Infection

View source ↗

Summary

This document notes that the clinical trial monitoring patients with primary or early HIV infection sponsored by NIAID has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Status: COMPLETED